Bavencio 200 mg Injection

Description

Bavencio 200 mg Injection contains Avelumab, an immunotherapy medicine used in the treatment of certain advanced cancers. It is a monoclonal antibody that enhances the body's immune response to identify and attack cancer cells. Bavencio is administered intravenously under the supervision of an oncologist in a medical facility.

Benefits

• Enhances the immune system’s ability to target cancer cells

• Improves treatment outcomes in patients with advanced cancers

• Provides a survival benefit in metastatic disease

• Safe for long-term maintenance therapy in responsive patients

• Effective when used alone or in combination with targeted therapy (e.g., axitinib)

Indications and Usage

Bavencio 200 mg Injection is prescribed for:

• Metastatic Merkel Cell Carcinoma (MCC)

• Locally advanced or metastatic Urothelial Carcinoma (UC) after disease progression

• Advanced Renal Cell Carcinoma (RCC) in combination with axitinib

• Certain other cancers as recommended by an oncologist

Usage must be guided and monitored by a cancer specialist.

How it Works

Avelumab is a PD-L1 inhibitor (Programmed Death-Ligand 1 inhibitor).

• Cancer cells express PD-L1 to evade immune detection.

• Bavencio blocks this PD-L1 signal, enabling T-cells (immune cells) to recognize and destroy cancer cells.

• This restores and strengthens the immune system’s natural anti-tumor activity.

Dosage & Administration

• Administered as an intravenous infusion

• Standard dose: 800 mg every 2 weeks (depending on regimen)

• Each infusion is given over approximately 60 minutes

• Premedication may be given to reduce infusion-related reactions

• Treatment continues until disease progression or unacceptable toxicity

Important: Bavencio should only be administered in a hospital or oncology center by trained healthcare professionals.

Side Effects

Common side effects:

• Fatigue

• Nausea

• Diarrhea

• Rash or itching

• Muscle or joint pain

• Fever or chills

Serious side effects (seek immediate medical attention):

• Immune-related reactions:

  • Pneumonitis (lung inflammation)

  • Hepatitis (liver inflammation)

  • Nephritis (kidney inflammation)

  • Colitis (severe diarrhea)

  • Endocrine disorders (thyroid/adrenal dysfunction)

• Severe infusion reactions

• Severe allergic responses

Warning and Precaution

• Not recommended during pregnancy or breastfeeding

• Monitor for immune-related side effects (lungs, liver, kidneys, colon, hormones)

• Regular blood tests required during treatment

• Inform doctor if you have autoimmune diseases

• Use cautiously in patients with organ transplants

• Report any of the following immediately:

  • Persistent cough, chest pain, or difficulty breathing

  • Severe abdominal pain or diarrhea

  • Yellowing of eyes/skin

  • Unusual fatigue or dizziness

  • Severe rash or swelling

• Avoid live vaccines during treatment